Aratrmalar, GLP-1in blood pressure zerinde de olumlu etkiler saladn, kalp saln desteklediini ortaya koymutur
(49) have confirmed that in vitro treatment with UA can reduce the expression levels of fibrosis markers including vimentin, discoidin domain receptor tyrosine kinase 2, tensin and Alpha-smooth muscle actin in myocardial tissues, and inhibit the transition of cardiac fibroblasts to a fibrotic state through nuclear factor erythroid 2-related factor 2 signaling pathway
Elife 9 , e51107 (2020)
If these policy shifts are successful, they could dramatically expand obesity drug coverage for millions of Americans
Retatrutide (30mg) from NewBioRx is a high-purity synthetic peptide designed as a triple agonist of the GLP-1, GIP, and glucagon (GCGR) receptors, allowing researchers to investigate coordinated incretin signaling and related pathways involved in glucose regulation, lipid metabolism, energy balance, and endocrine communication between tissues